BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11731472)

  • 1. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.
    Jackson PK
    Genes Dev; 2001 Dec; 15(23):3053-8. PubMed ID: 11731472
    [No Abstract]   [Full Text] [Related]  

  • 2. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
    Sachdev S; Bruhn L; Sieber H; Pichler A; Melchior F; Grosschedl R
    Genes Dev; 2001 Dec; 15(23):3088-103. PubMed ID: 11731474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
    Palvimo JJ
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1405-8. PubMed ID: 18031232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIAS proteins and transcriptional regulation--more than just SUMO E3 ligases?
    Sharrocks AD
    Genes Dev; 2006 Apr; 20(7):754-8. PubMed ID: 16600908
    [No Abstract]   [Full Text] [Related]  

  • 5. [Identification and function of ubiquitin-like protein SUMO E3 (PIAS family and RanBp2, Pc2)].
    Takahashi Y
    Seikagaku; 2004 Apr; 76(4):381-4. PubMed ID: 15162967
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction of AIRE with PIAS1 in transcriptional regulation.
    Ilmarinen T; Kangas H; Kytömaa T; Eskelin P; Saharinen J; Seeler JS; Tanhuanpää K; Chan FY; Slattery RM; Alakurtti K; Palvimo JJ; Ulmanen I
    Mol Immunol; 2008 Apr; 45(7):1847-62. PubMed ID: 18083234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
    Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
    Mol Cell Biol; 2002 Jul; 22(14):5222-34. PubMed ID: 12077349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
    Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
    Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIAS proteins: pleiotropic interactors associated with SUMO.
    Rytinki MM; Kaikkonen S; Pehkonen P; Jääskeläinen T; Palvimo JJ
    Cell Mol Life Sci; 2009 Sep; 66(18):3029-41. PubMed ID: 19526197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
    Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
    J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polycomb protein Pc2 is a SUMO E3.
    Kagey MH; Melhuish TA; Wotton D
    Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
    Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
    Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
    Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
    Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation.
    Li C; Boutet A; Pascariu CM; Nelson T; Courcelles M; Wu Z; Comtois-Marotte S; Emery G; Thibault P
    J Proteome Res; 2023 Mar; 22(3):812-825. PubMed ID: 36723483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO: ligases, isopeptidases and nuclear pores.
    Melchior F; Schergaut M; Pichler A
    Trends Biochem Sci; 2003 Nov; 28(11):612-8. PubMed ID: 14607092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.